Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Closing Bell 23 January

Grady Wulff
January 23, 2023

Morning Bell 23 January

Bell Direct
January 23, 2023

Weekly Wrap 20 January

Grady Wulff
January 20, 2023

Morning Bell 20 January

Grady Wulff
January 20, 2023

Closing Bell 19 January

Grady Wulff
January 19, 2023

Morning Bell 19 January

Sophia Mavridis
January 19, 2023

Closing Bell 18 January

Grady Wulff
January 18, 2023

Morning Bell 18 January

Grady Wulff
January 18, 2023

Closing Bell 17 January

Grady Wulff
January 17, 2023

Morning Bell 17 January

Sophia Mavridis
January 17, 2023

Closing Bell 16 January

Grady Wulff
January 16, 2023

Morning Bell 16 January

Grady Wulff
January 16, 2023